why choose us

Clinical Trials Search

Showing 9,140 of 132,656 result(s)
Effects of Clear Speech on Listening Effort and Memory in Sentence Processing

Status: Completed

Condition: Speech

Interventions: The sentences are designed such that a specific target word is either (a) Plausible (normal), (b) a semantic pragmatic violation, or (c) a morpho-synt

Date: 2023-08-17

A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combination With Chemotherapy Compared With Pembrolizumab in Combination With Chemotherapy in Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients

Status: NOT_YET_RECRUITING

Condition: Carcinoma, Non-Small-Cell Lung

Interventions: Participants will receive intravenous (IV) Durvalumab q3w for four 21-day cycles.
Durvalumab will also be given during the maintenance phase q4w

Date: 2023-08-17

Early Parkinson's Disease Monotherapy With CVN424

Status: Completed

Condition: Parkinson Disease

Interventions: Participants will receive 1 CVN424 tablet (150 mg) per day.

Date: 2023-08-17

Integrated Platform for Measuring and Reducing Symptoms of Autism Spectrum Disorder

Status: Completed

Condition: Autism Spectrum Disorder

Interventions: The children will wear the CognilumTM device for approximately 10 minutes at a time, twice a week, for a period of 10 weeks.

Date: 2023-08-17

A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer

Status: Completed

Condition: Non Small Cell Lung Cancer

Interventions: Lorlatinib 100 mg orally daily

Date: 2023-08-17

A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma

Status: Completed

Condition: Choroidal Melanoma

Interventions: Bel-sar via suprachoroidal administration followed by laser application.

Date: 2023-08-17

Tele-video to Improve Daily Activity

Status: COMPLETED

Condition: Physical Inactivity

Interventions: Participants will be asked to meet individually with an Occupational Therapist (OT) via Zoom to assess activity performance, establish short-term acti

Date: 2023-08-17

Characterizing Guideline Adoption and Treatment Quality in Clinical Routine of German HFrEF Care

Status: COMPLETED

Condition: Heart Failure

Interventions: There is no treatment allocation.
Patients are allocated to the respective cohort based on the treating physician enrolling them in the study.

Date: 2023-08-17

Early Parkinson's Disease Monotherapy With CVN424

Status: COMPLETED

Condition: Parkinson's Disease

Interventions: Participants will receive 1 CVN424 tablet (150 mg) per day.

Date: 2023-08-17